| Financial Year |
March 31 2023 |
| Monetary Funds |
6,208,227,515.16 |
| Held-for-trading Financial Assets |
157,610,557.90 |
| Notes Receivable |
-- |
| Accounts Receivable |
188,699,522.27 |
| Advances to Suppliers |
3,390,441,809.01 |
| Other Receivables |
301,999,380.14 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
12,401,123,431.76 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,551,370,357.36 |
| Total Current Assets |
24,199,472,573.60 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,046,000,158.74 |
| Investment Properties |
-- |
| Fixed Assetes |
13,130,380,664.53 |
| Under-construction Projects |
381,465,550.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,827,652,849.72 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
280,770,735.37 |
| Deferred Income Tax Assets |
251,067,223.36 |
| Other Non-Current Assets |
85,074,371.12 |
| Sub-Total of Non-Current Assets |
17,070,356,731.03 |
| Total Assets |
41,269,829,304.63 |
| Short-Term Loans |
6,097,820,935.92 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
3,726,818,551.64 |
| Accounts Received In Advance |
2,094,527.99 |
| Employee Compensation Payable |
84,151,078.91 |
| Taxes Payable |
225,900,382.80 |
| Interest Payable |
-- |
| Dividend Payable |
36,458,132.37 |
| Other payables |
483,617,983.21 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,350,346,472.52 |
| Other Current Liabilities |
86,018,642.27 |
| Sub-Total of Current Liabilities |
14,984,617,765.67 |
| Long-term Loans |
9,494,623,011.85 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
106,227,869.17 |
| Special Payable |
-- |
| Estimatied Liabilities |
235,401,466.39 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
9,882,127,877.54 |
| Total Liabilities |
24,866,745,643.21 |
| Paid-In Capital(Or Share Stock) |
2,003,628,310.00 |
| Capital Surplus |
8,006,532,801.78 |
| Surplus Reserve |
708,088,620.53 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,863,042,899.93 |
| Minority Stockholder's Interest |
2,852,155,466.98 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
13,550,928,194.44 |
| Owner's Equity（Stockholder's Equity） |
16,403,083,661.42 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
41,269,829,304.63 |
